(Press-News.org)
Building on the momentum of the 6th World Congress on Targeting Phage Therapy, that gathered more than 150 attendees from over 30 countries and featured over 71 presentations, the highly anticipated Targeting Phage Therapy 2024 is set to unfold.
Mark Your Agendas for the 7th World Congress on Targeting Phage Therapy
Date: June 20-21, 2024
Location: Corinthia Palace, Malta
What to Expect:
Cutting-edge insights into phage therapy advancements and its potential to revolutionize medicine.
Engaging keynotes and expert panels tackling current challenges head-on.
Focused discussions on regulatory frameworks, phage selection, and the critical role of clinical trials.
Gain insights into the direction of Targeting Phage Therapy 2024 by exploring the concluding remarks of 2023.
How to contribute?
We welcome submissions for innovative sessions and talks. If you have groundbreaking insights to share, be part of shaping tomorrow's medical landscape.
A Look Back at Targeting Phage Therapy 2023: Award Winners
1. Best Scientific Contribution
Martha Clockie, Editor in Chief of PHAGE Journal, University of Leicester, United Kingdom
Topic: Challenges and Opportunities for Bacteriophage Therapy
2. Best Scientific Innovation
Amanda (Curtis) Burkardt, CEO of PHIOGEN, USA
Topic: Creating Patient Ready Products in a Remedy Ready World.
3. Best Short Oral:
Brieuc Van Nieuwenhuyse, UC Louvain, Belgium
Topic: Bacteriophage-Antibiotic Combination to Allow Liver Transplantation
4. Best Poster:
Pantiora Panagiota, Agricultural University of Athens, Greece
Topic: Thermostable Bactericidal Endolysin Discovery
Revisit Targeting Phage Therapy 2023: Replay is Available
Explore the Targeting Phage Therapy 2023 replay to preview what's in store for 2024. Whether you missed the event or want to rewatch it, the replay is available. Access 40+ talks and innovations from key industries like Phiogen, Armata Pharmaceuticals, BiomX, Cellexus, and more.
The Abstracts Book is also accessible for additional insights.
Learn more about available materials.
Wishing you a joyous holiday season, we anticipate the pleasure of meeting you at Targeting Phage Therapy 2024 in Malta. For more information about the event, please visit our website.
END
Liver cancer screening among patients with cirrhosis almost doubled when they were mailed a signed order from their specialist, according to a new study from the Perelman School of Medicine at the University of Pennsylvania. However, when researchers added an incentive of $20 to the mailed orders, it made no difference in whether patients completed their screenings. The work was published this week in Hepatology Communications.
“Our findings show that an approach like this can meaningfully increase liver cancer surveillance, ...
Texas A&M University School of Public Health research on attitudes toward pet vaccination and how they may be linked with human vaccine hesitancy was the subject of a new study recently published in the journal Vaccine.
Simon Haeder, Ph.D., associate professor, analyzed data from an August 2023 survey of more than 2,000 dog and more than 1,400 cat owners to measure pet vaccination rates, perceptions of vaccines and support for pet vaccination requirements.
“Decreasing pet vaccination rates pose challenges to society for a number of reasons, including increased incidents ...
Writing in Nature Communications on November 24, engineers at Columbia and theoretical collaborators at the Max Planck for the Structure and Dynamics of Matter find that pairing laser light to crystal lattice vibrations can enhance the nonlinear optical properties of a layered 2D material.
Cecilia Chen, a Columbia Engineering PhD student and co-author of the recent paper, and her colleagues from Alexander Gaeta’s Quantum and Nonlinear Photonics group used hexagonal boron nitride (hBN). hBN is a 2D material similar to graphene: its atoms are arranged in a ...
Low-income U.S. veterans who are experiencing feelings of loneliness are more likely to purchase firearms, according to new research from UTHealth Houston.
A study led by principal investigator Alexander Testa, PhD, assistant professor, and co-investigator Jack Tsai, PhD, professor, from the Department of Management, Policy and Community Health with UTHealth Houston School of Public Health, was published recently in Social Science & Medicine.
“Loneliness was significantly associated with a higher likelihood ...
Waltham — December 19, 2023 — For patients undergoing total knee arthroplasty (TKA), treatment with diosmin – a flavonoid supplement derived from citrus fruits –reduced swelling of the knee and leg and some measures of associated pain can be achieved, reports a clinical trial in The Journal of Bone & Joint Surgery. The journal is published in the Lippincott portfolio in partnership with Wolters Kluwer.
"The use of diosmin after TKA reduced lower-extremity swelling and pain during motion and was not associated with an increased incidence of short-term complications involving the outcomes studied," according ...
There does not appear to be any profound differences between so-called exposure-based CBT and traditional CBT in the treatment of fibromyalgia, according to a study led by researchers at Karolinska Institutet. Both forms of treatment produced a significant reduction in symptoms in people affected by the disease. The study is one of the largest to date to compare different treatment options for fibromyalgia and is published in the journal PAIN.
About 200,000 people in Sweden currently live with fibromyalgia, a long-term pain syndrome that causes great suffering for patients through widespread pain, fatigue, and stiffness in the body. There is no cure ...
People who maintain or increase their aerobic fitness are at less risk of being hospitalized in future, particularly if they were hospitalized previously. These are the findings of a study conducted at the University of Gothenburg.
Regular physical activity is linked to a number of health benefits, including a reduced risk of developing and dying from cardiovascular disease. However, there has been little research into the link between development of aerobic fitness and the likelihood of being hospitalized.
The study in question, published in the European Journal of Preventive Cardiology, includes ...
A new study published today (22 December 2023) in Nature Communications details that markers of brain injury are present in the blood many months after COVID-19 infection, despite inflammation blood tests being normal.
The findings represent a major output from the University of Liverpool and King’s College London led COVID-19 Clinical Neuroscience Study (COVID-CNS) and also involves scientists from the ISARIC4C consortium, The Pandemic Institute and the NIHR BioResource.
Professor Benedict Michael, Principal Investigator and Director of the University of Liverpool’s Infection Neuroscience Laboratory ...
Antibiotic-resistant bacteria have become a rapidly growing threat to public health. Each year, they account for more than 2.8 million infections, according to the U.S. Centers for Disease Control and Prevention. Without new antibiotics, even common injuries and infections harbor the potential to become lethal.
Scientists are now one step closer to eliminating that threat, thanks to a Texas A&M University-led collaboration that has developed a new family of polymers capable of killing bacteria without inducing antibiotic resistance by disrupting the membrane of these microorganisms.
“The new polymers we synthesized could help fight antibiotic ...
At about the size of a pinkie nail, the jellyfish species Cladonema can regenerate an amputated tentacle in two to three days — but how? Regenerating functional tissue across species, including salamanders and insects, relies on the ability to form a blastema, a clump of undifferentiated cells that can repair damage and grow into the missing appendage. Jellyfish, along with other cnidarians such as corals and sea anemones, exhibit high regeneration abilities, but how they form the critical blastema has remained a mystery until now.
A research team based in Japan has revealed that stem-like proliferative cells — which are actively growing and dividing but ...
